Combata el COVID con Anticuerpos Monoclonales (mAbs)

Monoclonal Antibody Treatment for COVID-19
At Home & No-Cost

If you have tested positive for COVID-19 you may qualify for Monoclonal Antibody Treatment

Introduzca su código postal para ver si califica

Protéjase

Monoclonal Antibodies can reduce your symptoms and potentially prevent hospitalization.

Autorizado por la FDA

Para uso de emergencia de aquellos que están en riesgo de contraer síntomas más serios o con factores de alto riesgo para el COVID.

A su Alcance, en su Hogar y sin Costo Alguno

No out of pocket costs and fully covered by all insurances.

Tratando el COVID19

Terapias con Anticuerpos Monoclonales en su Hogar

Monoclonal Antibody Therapy can reduce COVID-19 symptoms, hospitalization or emergency room visits when administered within 7 days of symptom onset.

Disminución del 70%-85% de hospitalización y muerte en los pacientes.

Disminución del 80% de infección en los hogares de los pacientes.

This is an outpatient treatment, administered through injections. We offer this treatment free for qualifying individuals who have tested positive for COVID-19.

¿Quién es elegible?

Approximately 85% of American adults who have tested positive qualify for this treatment.

mAbs are authorized for use on people ages 12+, who have tested positive for COVID-19.

Lo que Usted Puede Hacer

Combata el Covid-19 Ahora

Introduzca su código postal para ver si califica

Protect Yourself​

Protéjase

Monoclonal Antibodies can reduce your symptoms and potentially prevent hospitalization.

Autorizado por la FDA

Autorizado por la FDA

Para uso de emergencia de aquellos que están en riesgo de contraer síntomas más serios o con factores de alto riesgo para el COVID.

A su Alcance, en su Hogar y sin Costo Alguno

A su Alcance, en su Hogar y sin Costo Alguno

No out of pocket costs and fully covered by all insurances.
Acerca de los Anticuerpos Monoclonales (mAbs)

Acerca de la Terapia con Anticuerpos Monoclonales

Administered by IV (through a vein) or by injection, these outpatient COVID treatments have been shown to reduce hospitalization or emergency room visits when received early. They have also shown to reduce viral load and reduce days of symptoms. We use the Bebtelovimab authorized monoclonal antibody therapies which is manufactured by Eli Lilly.

¿Quién puede recibir Terapia con Anticuerpos Monoclonales?

These medicines are authorized for use on people ages 12 and older. If they have tested positive for COVID-19 and meet other specific criteria, they may qualify.

Para más información acerca de estos tratamientos, los criterios específicos y los posibles efectos secundarios, por favor, lea la Hoja Informativa para el Paciente.

Testimonial

My husband had Covid and is high risk. I am high risk as well. Within minutes of filling out an online application for Monoclonal antibody treatment, we received a phone call from Mabsathome. Within a couple of hours, there was a nurse at our house administering the antibody treatment. We could not have asked for better treatment, communication and care. Thank you so much for being there for us. This is truly a lifesaving treatment with little to no side effects. My husband was feeling better the next day and recovered quickly from Covid.

Connie W

Baltimore MD

Tratamiento con Anticuerpos Monoclonales (mAbs)

Covid-19 Treatment in 5 Steps

Introduzca su código postal

Introduzca su código postal para determinar su elegibilidad para este programa

Rellene el formulario

Rellene el formulario de calificación

Nosotros lo Revisamos

A staff member will review and determine eligibility.

Haga una cita

A medical professional will contact you to schedule your appointment.

Tratamiento con Anticuerpos Monoclonales (mAbs)

A medical professional will monitor vitals prior to receiving treatment. Receiving mAbs intravenously takes a few minutes. The medical professional will continue monitoring all vitals during the required observation period.

¿Está listo para protegerse a usted y a sus seres queridos?

Introduzca su código postal para ver si califica

Preguntas Frecuentes

Preguntas Frecuentes

Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful viruses like SARS-CoV-2. Monoclonal antibodies attack the virus and reduce its ability to spread throughout your body.

No. Vaccination remains the most powerful tool against contracting Covid-19, as well as against hospitalization and death from Covid. mAbs is a therapy that helps those who have tested positive for Covid-19.

Yes. Those who test positive for COVID-19  are eligible to receive monoclonal antibody treatment even if previously vaccinated.
Si, aunque se recomienda esperar 90 días después del tratamiento para recibir la vacuna.
No. Los anticuerpos no contienen al virus vivo.

Los Anticuerpos Monoclonales (mAbs) han sido autorizados por la FDA para uso de emergencia. Cualquier infusión o inyección puede causar efectos secundarios como: dolor breve, sangrado, moretones, dolor, hinchazón, fiebre, escalofríos, agotamiento, náuseas, dolor de cabeza y posible infección en el área de la infusión. Raramente pueden ocurrir reacciones alérgicas e hipersensibilidad durante o después de la infusión de anticuerpos. Por esta razón, usted será monitoreado por personal de salud entrenado durante y después del tratamiento.

Early treatment with mAbs may prevent the disease from worsening and lessen the length of your symptoms. Additionally, it can protect your household from contracting Covid from you.

Yes, monoclonal antibody treatment is administered at no cost to the patient. It is covered by all insurances.

Fill out your zip code on our website to get started. Once you qualify, we’ll reach out to you to schedule treatment. Treatment will be administered by a trained professional in the comfort of your own home. You can also search for a site by going to the U.S. Department of Health and Human Services website, or by calling them at 1-877-332-6585 (for English) or 1-877-366-0310 (for Spanish).

We're hiring

Español de México